HS2 Stock Overview
Henry Schein, Inc. provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 2/6 |
| Past Performance | 1/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Henry Schein, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$63.84 |
| 52 Week High | US$82.63 |
| 52 Week Low | US$63.78 |
| Beta | 0.82 |
| 1 Month Change | 0% |
| 3 Month Change | 0.094% |
| 1 Year Change | -14.97% |
| 3 Year Change | 12.93% |
| 5 Year Change | n/a |
| Change since IPO | 79.83% |
Recent News & Updates
Recent updates
Shareholder Returns
| HS2 | DE Healthcare | DE Market | |
|---|---|---|---|
| 7D | 0% | 2.2% | 2.5% |
| 1Y | -15.0% | -1.1% | 6.0% |
Return vs Industry: HS2 underperformed the German Healthcare industry which returned -1% over the past year.
Return vs Market: HS2 underperformed the German Market which returned -1.2% over the past year.
Price Volatility
| HS2 volatility | |
|---|---|
| HS2 Average Weekly Movement | n/a |
| Healthcare Industry Average Movement | 6.2% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 10.4% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: HS2 has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine HS2's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1932 | 24,000 | Stan Bergman | www.henryschein.com |
Henry Schein, Inc. provides health care products and services to dental practitioners and laboratories, physician practices, ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, personal protective equipment, and high-tech and digital restoration equipment, as well as equipment repair services.
Henry Schein, Inc. Fundamentals Summary
| HS2 fundamental statistics | |
|---|---|
| Market cap | €8.83b |
| Earnings (TTM) | €408.47m |
| Revenue (TTM) | €11.65b |
21.6x
P/E Ratio0.8x
P/S RatioIs HS2 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| HS2 income statement (TTM) | |
|---|---|
| Revenue | US$12.69b |
| Cost of Revenue | US$8.76b |
| Gross Profit | US$3.94b |
| Other Expenses | US$3.49b |
| Earnings | US$445.00m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 3.42 |
| Gross Margin | 31.00% |
| Net Profit Margin | 3.51% |
| Debt/Equity Ratio | 37.0% |
How did HS2 perform over the long term?
See historical performance and comparison